In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Amgen's Ilypsa subsidiary has spun-off Relypsa (polymeric therapeutics for renal and cardiovascular diseases). The company has raised $33mm through the closing of its Series A venture round. 5AM Ventures and New Leaf Venture Partners led the financing and were joined by the Sprout Group, Delphi Ventures, CMEA Ventures, and Mediphase Venture Partners.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?